THROMBOEMBOLISM
Clinical trials for THROMBOEMBOLISM explained in plain language.
Never miss a new study
Get alerted when new THROMBOEMBOLISM trials appear
Sign up with your email to follow new studies for THROMBOEMBOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
C-Section blood clot prevention: small study tests feasibility
Disease control CompletedThis pilot study looked at whether it's practical to give a blood thinner (low molecular weight heparin) to women after a C-section to prevent blood clots. 64 women were randomly assigned to receive the drug or no treatment. The main goal was to see if enough women would join and…
Matched conditions: THROMBOEMBOLISM
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Which blood clot drug costs less for cancer patients? new study digs into the data
Knowledge-focused CompletedThis study looked at insurance records from over 7,300 cancer patients who had a blood clot (VTE) and were treated with either apixaban or low molecular weight heparin (LMWH). The goal was to compare total healthcare costs, including hospital stays, outpatient visits, and pharmac…
Matched conditions: THROMBOEMBOLISM
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC